Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.

Blanke CD, Stipanov M, Morrow J, Rothenberg M, Chinery R, Shyr Y, Coffey R, Johnson DH, Leach SD, Beauchamp RD.

Invest New Drugs. 2001;19(1):21-7.

PMID:
11291830
[PubMed - indexed for MEDLINE]
2.

The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.

Mosconi S, Cascinu S, Zaniboni A, Catalano V, Giordani P, Beretta GD, Martignoni G, Pancera G, Baldelli AM, Poletti P, Curti C, Labianca R.

Tumori. 2000 Nov-Dec;86(6):465-9.

PMID:
11218187
[PubMed - indexed for MEDLINE]
3.

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.

Saltz LB, Kanowitz J, Kemeny NE, Schaaf L, Spriggs D, Staton BA, Berkery R, Steger C, Eng M, Dietz A, Locker P, Kelsen DP.

J Clin Oncol. 1996 Nov;14(11):2959-67.

PMID:
8918493
[PubMed - indexed for MEDLINE]
4.

A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma.

Kalofonos HP, Skarlos D, Bafaloukos D, Papakostas P, Bamias A, Janinis J, Timotheadou E, Kouvatseas G, Stavropoulos M, Economopulos T, Fountzilas G.

Cancer Invest. 2003;21(6):855-62.

PMID:
14735689
[PubMed - indexed for MEDLINE]
5.

Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.

Comella P, Casaretti R, De Rosa V, Avallone A, Izzo F, Fiore F, Lapenta L, Comella G.

Ann Oncol. 2002 Dec;13(12):1874-81.

PMID:
12453855
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer.

Rosati G, Rossi A, Tucci A, Pizza C, Manzione L.

Ann Oncol. 2001 May;12(5):669-74.

PMID:
11432626
[PubMed - indexed for MEDLINE]
Free Article
7.

A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.

Kim BG, Oh SY, Kwon HC, Lee S, Lee DM, Kim SG, Kim DK, Jang JS, Kim MC, Kim SH, Kim HJ.

Am J Clin Oncol. 2010 Jun;33(3):246-50. doi: 10.1097/COC.0b013e3181a650d4.

PMID:
19770628
[PubMed - indexed for MEDLINE]
8.

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Mani S, Rudin CM, Kunkel K, Holmlund JT, Geary RS, Kindler HL, Dorr FA, Ratain MJ.

Clin Cancer Res. 2002 Apr;8(4):1042-8.

PMID:
11948111
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.

Jpn J Clin Oncol. 2007 Sep;37(9):686-91. Epub 2007 Aug 24.

PMID:
17720736
[PubMed - indexed for MEDLINE]
Free Article
10.

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.

Ychou M, Conroy T, Seitz JF, Gourgou S, Hua A, Mery-Mignard D, Kramar A.

Ann Oncol. 2003 Mar;14(3):481-9.

PMID:
12598357
[PubMed - indexed for MEDLINE]
Free Article
11.

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.

Blanke CD, Kasimis B, Schein P, Capizzi R, Kurman M.

J Clin Oncol. 1997 Mar;15(3):915-20.

PMID:
9060528
[PubMed - indexed for MEDLINE]
12.

5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.

Tsavaris NB, Tentas K, Kosmidis P, Mylonakis N, Sakelaropoulos N, Kosmas C, Lisaios B, Soumilas A, Mandrekois D, Tsetis A, Klonaris C.

Am J Clin Oncol. 1996 Oct;19(5):517-21.

PMID:
8823483
[PubMed - indexed for MEDLINE]
13.

Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.

J Clin Oncol. 2004 Dec 1;22(23):4753-61. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570076
[PubMed - indexed for MEDLINE]
14.

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV Jr, Markowitz AB, Abbruzzese JL, Bready B, et al.

J Clin Oncol. 1994 Nov;12(11):2296-300.

PMID:
7964943
[PubMed - indexed for MEDLINE]
15.

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.

Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY.

Cancer. 1995 Dec 1;76(11):2186-92.

PMID:
8635020
[PubMed - indexed for MEDLINE]
16.

Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies.

Valone FH, Gandara DR, Luce JA, Wall S, Perez EA, Braham N, George M, Letvak L.

Cancer Chemother Pharmacol. 1993;32(3):215-20.

PMID:
8500227
[PubMed - indexed for MEDLINE]
17.

Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.

J├Ąger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum B├╝schenfelde KH, Knuth A.

J Clin Oncol. 1996 Aug;14(8):2274-9.

PMID:
8708717
[PubMed - indexed for MEDLINE]
18.

Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group.

Comella P, Casaretti R, De Vita F, Avallone A, Orditura M, Petrillo A, Gravina A, Faranda A, Comis S, Comella G, Catalano G.

Ann Oncol. 1999 Aug;10(8):915-21.

PMID:
10509152
[PubMed - indexed for MEDLINE]
Free Article
19.

A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer.

Kim SR, Yuh YJ, Sohn BS, Yang SH.

Tumori. 2011 Nov-Dec;97(6):698-703. doi: 10.1700/1018.11084.

PMID:
22322834
[PubMed - indexed for MEDLINE]
20.

A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.

Souglakos J, Kakolyris S, Vardakis N, Androulakis N, Mavroudis D, Vamvakas L, Kouroussis C, Agelaki S, Saridaki Z, Georgoulias V.

Cancer Invest. 2005;23(6):505-10.

PMID:
16203658
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk